Limitations of Aneuploidy and Anomaly Detection in the Obese Patient
Abstract
:1. Introduction
1.1. Worldwide Scope of the Obesity Problem
1.2. Implications of Maternal Obesity and Weight Gain in Pregnancy
2. Aneuploidy Detection
2.1. Nuchal Translucency Screening
2.2. Serum Biochemical Screening
2.3. Non-Invasive Prenatal Testing
2.4. Ultrasonographic Marker Screening (“Soft Markers”)
2.5. Diagnostic Testing for Aneuploidy
3. Anomaly Detection
3.1. Early Anatomy Survey
3.2. Limitations of Second-Trimester Ultrasound
3.3. Completion of Anatomic Surveys
3.4. Performance in Anomaly Detection
3.5. Techniques to Improve Visualization
4. Conclusions
Author Contributions
Conflicts of Interest
References
- WHO Expert Committee. Physical status: The use and interpretation of anthropometry. Available online: http://www.who.int/nutrition/publications/growth_physical_status/en/ (accessed on 10 April 2014).
- WHO Consultation on Obesity. Obesity: Preventing and managing the global epidemic. Available online: http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/ (accessed on 10 April 2014).
- Ogden, C.L.; Carroll, M.D.; Kit, B.K.; Flegal, K.M. Prevalence of obesity among adults: United States, 2011–2012. NCHS Data Brief 2013, 131, 1–8. [Google Scholar] [PubMed]
- Cedergren, M.I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet. Gynecol. 2004, 103, 219–224. [Google Scholar] [CrossRef] [PubMed]
- Blomberg, M.I.; Kallen, B. Maternal obesity and morbid obesity: The risk for birth defects in the offspring. Birth Defects Res. A Clin. Mol. Teratol. 2010, 88, 35–40. [Google Scholar] [PubMed]
- Hall, L.F.; Neubert, A.G. Obesity and pregnancy. Obstet. Gynecol. Surv. 2005, 60, 253–260. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Nutrition Section Controlling the Global Obesity Epidemic. Available online: http://www.who.int/nutrition/topics/obesity/en/ (accessed on 15 December 2013).
- Monteiro, C.A.; Conde, W.L.; Popkin, B.M. Is obesity replacing or adding to undernutrition? Evidence from different social classes in Brazil. Public Health Nutr. 2002, 5, 105–112. [Google Scholar] [CrossRef] [PubMed]
- Caterson, I.D.; Gill, T.P. Obesity: Epidemiology and possible prevention. Best Pract. Res. Clin. Endocrinol. Metab. 2002, 16, 595–610. [Google Scholar] [CrossRef] [PubMed]
- Perez Rodrigo, C. Current mapping of obesity. Nutr. Hosp. 2013, 28, 21–31. [Google Scholar] [PubMed]
- James, P.T. Obesity: The worldwide epidemic. Clin. Dermatol. 2004, 22, 276–280. [Google Scholar] [CrossRef] [PubMed]
- National Research Council and Institute of Medicine. Influence of Pregnancy Weight on Maternal and Child Health: Workshop Report; The National Academies Press: Washington, DC, USA, 2007. [Google Scholar]
- Nguyen, N.T.; Magno, C.P.; Lane, K.T.; Hinojosa, M.W.; Lane, J.S. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: Findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J. Am. Coll. Surg. 2008, 207, 928–934. [Google Scholar] [CrossRef] [PubMed]
- Wilson, P.W.; D’Agostino, R.B.; Sullivan, L.; Parise, H.; Kannel, W.B. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch. Intern. Med. 2002, 162, 1867–1872. [Google Scholar] [CrossRef] [PubMed]
- Colditz, G.A.; Willett, W.C.; Rotnitzky, A.; Manson, J.E. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann. Intern. Med. 1995, 122, 481–486. [Google Scholar] [CrossRef] [PubMed]
- Lu, G.C.; Rouse, D.J.; DuBard, M.; Cliver, S.; Kimberlin, D.; Hauth, J.C. The effect of the increasing prevalence of maternal obesity on perinatal morbidity. Am. J. Obstet. Gynecol. 2001, 185, 845–849. [Google Scholar] [CrossRef] [PubMed]
- Oken, E.; Taveras, E.M.; Popoola, F.A.; Rich-Edwards, J.W.; Gillman, M.W. Television, walking, and diet: Associations with postpartum weight retention. Am. J. Prev. Med. 2007, 32, 305–311. [Google Scholar] [CrossRef] [PubMed]
- Rooney, B.L.; Schauberger, C.W. Excess pregnancy weight gain and long-term obesity: One decade later. Obstet. Gynecol. 2002, 100, 245–252. [Google Scholar] [CrossRef] [PubMed]
- Correa, A.; Gilboa, S.M.; Botto, L.D.; Moore, C.A.; Hobbs, C.A.; Cleves, M.A.; Riehle-Colarusso, T.J.; Waller, D.K.; Reece, E.A. National Birth Defects Prevention Study Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am. J. Obstet. Gynecol. 2012, 206. [Google Scholar] [CrossRef]
- Correa, A.; Gilboa, S.M.; Besser, L.M.; Botto, L.D.; Moore, C.A.; Hobbs, C.A.; Cleves, M.A.; Riehle-Colarusso, T.J.; Waller, D.K.; Reece, E.A. Diabetes mellitus and birth defects. Am. J. Obstet. Gynecol. 2008, 199. [Google Scholar] [CrossRef] [PubMed]
- Stothard, K.J.; Tennant, P.W.; Bell, R.; Rankin, J. Maternal overweight and obesity and the risk of congenital anomalies: A systematic review and meta-analysis. JAMA 2009, 301, 636–650. [Google Scholar] [CrossRef] [PubMed]
- Gurram, P.; Benn, P.; Campbell, W.A. Impact of diabetes on aneuploidy screening. Clin. Lab. Med. 2013, 33, 271–280. [Google Scholar] [CrossRef] [PubMed]
- American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet. Gynecol. 2007, 110, 1459–1467. [Google Scholar]
- Cuckle, H.; Benn, P.; Wright, D. Down syndrome screening in the first and/or second trimester: Model predicted performance using meta-analysis parameters. Semin. Perinatol. 2005, 29, 252–257. [Google Scholar] [CrossRef] [PubMed]
- Krantz, D.A.; Larsen, J.W.; Buchanan, P.D.; Macri, J.N. First-trimester Down syndrome screening: Free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Am. J. Obstet. Gynecol. 1996, 174, 612–616. [Google Scholar] [CrossRef] [PubMed]
- Gandhi, M.; Fox, N.S.; Russo-Stieglitz, K.; Hanley, M.E.; Matthews, G.; Rebarber, A. Effect of increased body mass index on first-trimester ultrasound examination for aneuploidy risk assessment. Obstet. Gynecol. 2009, 114, 856–859. [Google Scholar] [CrossRef] [PubMed]
- Thornburg, L.L.; Mulconry, M.; Post, A.; Carpenter, A.; Grace, D.; Pressman, E.K. Fetal nuchal translucency thickness evaluation in the overweight and obese gravida. Ultrasound Obstet. Gynecol. 2009, 33, 665–669. [Google Scholar] [CrossRef] [PubMed]
- Nicolaides, K.H. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am. J. Obstet. Gynecol. 2004, 191, 45–67. [Google Scholar] [CrossRef] [PubMed]
- Malone, F.D.; Canick, J.A.; Ball, R.H.; Nyberg, D.A.; Comstock, C.H.; Bukowski, R.; Berkowitz, R.L.; Gross, S.J.; Dugoff, L.; Craigo, S.D.; et al. First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium First-trimester or second-trimester screening, or both, for Down’s syndrome. N. Engl. J. Med. 2005, 353, 2001–2011. [Google Scholar] [CrossRef] [PubMed]
- Krantz, D.A.; Hallahan, T.W.; Sherwin, J.E. Screening for open neural tube defects. Clin. Lab. Med. 2010, 30, 721–725. [Google Scholar] [CrossRef] [PubMed]
- Wapner, R.; Thom, E.; Simpson, J.L.; Pergament, E.; Silver, R.; Filkins, K.; Platt, L.; Mahoney, M.; Johnson, A.; Hogge, W.A.; et al. First-trimester screening for trisomies 21 and 18. N. Engl. J. Med. 2003, 349, 1405–1413. [Google Scholar] [CrossRef] [PubMed]
- Breathnach, F.M.; Malone, F.D.; Lambert-Messerlian, G.; Cuckle, H.S.; Porter, T.F.; Nyberg, D.A.; Comstock, C.H.; Saade, G.R.; Berkowitz, R.L.; Klugman, S.; et al. First and Second Trimester Evaluation of Risk (FASTER) Research Consortium First- and second-trimester screening: Detection of aneuploidies other than Down syndrome. Obstet. Gynecol. 2007, 110, 651–657. [Google Scholar] [CrossRef] [PubMed]
- Krantz, D.A.; Hallahan, T.W.; Macri, V.J.; Macri, J.N. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program. Prenat. Diagn. 2005, 25, 635–640. [Google Scholar] [CrossRef] [PubMed]
- Neveux, L.M.; Palomaki, G.E.; Larrivee, D.A.; Knight, G.J.; Haddow, J.E. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat. Diagn. 1996, 16, 1115–1119. [Google Scholar] [CrossRef] [PubMed]
- Drugan, A.; Dvorin, E.; Johnson, M.P.; Uhlmann, W.R.; Evans, M.I. The inadequacy of the current correction for maternal weight in maternal serum alpha-fetoprotein interpretation. Obstet. Gynecol. 1989, 74, 698–701. [Google Scholar] [PubMed]
- Spencer, K.; Bindra, R.; Nicolaides, K.H. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat. Diagn. 2003, 23, 851–855. [Google Scholar] [CrossRef] [PubMed]
- Racusin, D.; Stevens, B.; Campbell, G.; Aagaard, K.M. Obesity and the risk and detection of fetal malformations. Semin. Perinatol. 2012, 36, 213–221. [Google Scholar] [CrossRef] [PubMed]
- Wald, N.J.; Cuckle, H.S.; Densem, J.W.; Kennard, A.; Smith, D. Maternal serum screening for Down’s syndrome: The effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br. J. Obstet. Gynaecol. 1992, 99, 144–149. [Google Scholar] [CrossRef] [PubMed]
- Palomaki, G.E.; Knight, G.J.; Kloza, E.M.; Haddow, J.E. Maternal weight adjustment and low serum alpha-fetoprotein values. Lancet 1985, 1, 468. [Google Scholar] [CrossRef] [PubMed]
- Huang, T.; Meschino, W.S.; Okun, N.; Dennis, A.; Hoffman, B.; Lepage, N.; Rashid, S.; Aul, R.; Farrell, S.A. The impact of maternal weight discrepancies on prenatal screening results for Down syndrome. Prenat. Diagn. 2013, 33, 471–476. [Google Scholar] [CrossRef] [PubMed]
- Bianchi, D.W.; Platt, L.D.; Goldberg, J.D.; Abuhamad, A.Z.; Sehnert, A.J.; Rava, R.P.; MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet. Gynecol. 2012, 119, 890–901. [Google Scholar] [CrossRef] [PubMed]
- Palomaki, G.E.; Kloza, E.M.; Lambert-Messerlian, G.M.; Haddow, J.E.; Neveux, L.M.; Ehrich, M.; van den Boom, D.; Bombard, A.T.; Deciu, C.; Grody, W.W.; et al. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genet. Med. 2011, 13, 913–920. [Google Scholar] [CrossRef] [PubMed]
- Palomaki, G.E.; Deciu, C.; Kloza, E.M.; Lambert-Messerlian, G.M.; Haddow, J.E.; Neveux, L.M.; Ehrich, M.; van den Boom, D.; Bombard, A.T.; Grody, W.W.; et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: An international collaborative study. Genet. Med. 2012, 14, 296–305. [Google Scholar] [CrossRef] [PubMed]
- Chiu, R.W.; Akolekar, R.; Zheng, Y.W.; Leung, T.Y.; Sun, H.; Chan, K.C.; Lun, F.M.; Go, A.T.; Lau, E.T.; To, W.W.; et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. BMJ 2011, 342. [Google Scholar] [CrossRef] [Green Version]
- Ehrich, M.; Deciu, C.; Zwiefelhofer, T.; Tynan, J.A.; Cagasan, L.; Tim, R.; Lu, V.; McCullough, R.; McCarthy, E.; Nygren, A.O.; et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting. Am. J. Obstet. Gynecol. 2011, 204. [Google Scholar] [CrossRef]
- Sehnert, A.J.; Rhees, B.; Comstock, D.; de Feo, E.; Heilek, G.; Burke, J.; Rava, R.P. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin. Chem. 2011, 57, 1042–1049. [Google Scholar] [CrossRef] [PubMed]
- Sparks, A.B.; Wang, E.T.; Struble, C.A.; Barrett, W.; Stokowski, R.; McBride, C.; Zahn, J.; Lee, K.; Shen, N.; Doshi, J.; et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat. Diagn. 2012, 32, 3–9. [Google Scholar] [CrossRef] [PubMed]
- Wang, E.; Batey, A.; Struble, C.; Musci, T.; Song, K.; Oliphant, A. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat. Diagn. 2013, 33, 662–666. [Google Scholar] [CrossRef] [PubMed]
- Benn, P.; Cuckle, H.; Pergament, E. Non-invasive prenatal testing for aneuploidy: Current status and future prospects. Ultrasound Obstet. Gynecol. 2013, 42, 15–33. [Google Scholar] [CrossRef] [PubMed]
- Ashoor, G.; Syngelaki, A.; Poon, L.C.; Rezende, J.C.; Nicolaides, K.H. Fetal fraction in maternal plasma cell-free DNA at 11–13 weeks’ gestation: Relation to maternal and fetal characteristics. Ultrasound Obstet. Gynecol. 2013, 41, 26–32. [Google Scholar] [CrossRef] [PubMed]
- Canick, J.A.; Palomaki, G.E.; Kloza, E.M.; Lambert-Messerlian, G.M.; Haddow, J.E. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat. Diagn. 2013, 33, 667–674. [Google Scholar] [CrossRef] [PubMed]
- Ghanta, S.; Mitchell, M.E.; Ames, M.; Hidestrand, M.; Simpson, P.; Goetsch, M.; Thilly, W.G.; Struble, C.A.; Tomita-Mitchell, A. Non-invasive prenatal detection of trisomy 21 using tandem single nucleotide polymorphisms. PLoS One 2010, 5, e13184. [Google Scholar] [CrossRef]
- Aagaard-Tillery, K.M.; Flint Porter, T.; Malone, F.D.; Nyberg, D.A.; Collins, J.; Comstock, C.H.; Hankins, G.; Eddleman, K.; Dugoff, L.; Wolfe, H.M.; et al. Influence of maternal BMI on genetic sonography in the FaSTER trial. Prenat. Diagn. 2010, 30, 14–22. [Google Scholar] [PubMed]
- Aagaard-Tillery, K.M.; Malone, F.D.; Nyberg, D.A.; Porter, T.F.; Cuckle, H.S.; Fuchs, K.; Sullivan, L.; Comstock, C.H.; Saade, G.R.; Eddleman, K.; et al. First and Second Trimester Evaluation of Risk Research Consortium Role of second-trimester genetic sonography after Down syndrome screening. Obstet. Gynecol. 2009, 114, 1189–1196. [Google Scholar] [CrossRef] [PubMed]
- Tsai, L.J.; Ho, M.; Pressman, E.K.; Thornburg, L.L. Ultrasound screening for fetal aneuploidy using soft markers in the overweight and obese gravida. Prenat. Diagn. 2010, 30, 821–826. [Google Scholar] [CrossRef] [PubMed]
- Harper, L.M.; Cahill, A.G.; Smith, K.; Macones, G.A.; Odibo, A.O. Effect of maternal obesity on the risk of fetal loss after amniocentesis and chorionic villus sampling. Obstet. Gynecol. 2012, 119, 745–751. [Google Scholar] [CrossRef] [PubMed]
- Rossi, A.C.; Prefumo, F. Accuracy of ultrasonography at 11–14 weeks of gestation for detection of fetal structural anomalies: A systematic review. Obstet. Gynecol. 2013, 122, 1160–1167. [Google Scholar] [CrossRef] [PubMed]
- American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 101: Ultrasonography in pregnancy. Obstet. Gynecol. 2009, 113, 451–461. [Google Scholar]
- American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of obstetric ultrasound examinations. J. Ultrasound Med. 2013, 32, 1083–1101. [Google Scholar]
- Phatak, M.; Ramsay, J. Impact of maternal obesity on procedure of mid-trimester anomaly scan. J. Obstet. Gynaecol. 2010, 30, 447–450. [Google Scholar] [CrossRef] [PubMed]
- Benacerraf, B.R. A technical tip on scanning obese gravidae. Ultrasound Obstet. Gynecol. 2010, 35, 615–616. [Google Scholar] [CrossRef] [PubMed]
- Weichert, J.; Hartge, D.R. Obstetrical sonography in obese women: A review. J. Clin. Ultrasound 2011, 39, 209–216. [Google Scholar] [CrossRef] [PubMed]
- Wolfe, H.M.; Sokol, R.J.; Martier, S.M.; Zador, I.E. Maternal obesity: A potential source of error in sonographic prenatal diagnosis. Obstet. Gynecol. 1990, 76, 339–342. [Google Scholar] [PubMed]
- Fuchs, F.; Houllier, M.; Voulgaropoulos, A.; Levaillant, J.M.; Colmant, C.; Bouyer, J.; Senat, M.V. Factors affecting feasibility and quality of second-trimester ultrasound scans in obese pregnant women. Ultrasound Obstet. Gynecol. 2013, 41, 40–46. [Google Scholar] [CrossRef] [PubMed]
- Dashe, J.S.; McIntire, D.D.; Twickler, D.M. Maternal obesity limits the ultrasound evaluation of fetal anatomy. J. Ultrasound Med. 2009, 28, 1025–1030. [Google Scholar] [PubMed]
- Thornburg, L.L.; Miles, K.; Ho, M.; Pressman, E.K. Fetal anatomic evaluation in the overweight and obese gravida. Ultrasound Obstet. Gynecol. 2009, 33, 670–675. [Google Scholar] [CrossRef] [PubMed]
- Chung, J.H.; Pelayo, R.; Hatfield, T.J.; Speir, V.J.; Wu, J.; Caughey, A.B. Limitations of the fetal anatomic survey via ultrasound in the obese obstetrical population. J. Matern. Fetal Neonatal Med. 2012, 25, 1945–1949. [Google Scholar] [CrossRef] [PubMed]
- Hendler, I.; Blackwell, S.C.; Bujold, E.; Treadwell, M.C.; Wolfe, H.M.; Sokol, R.J.; Sorokin, Y. The impact of maternal obesity on midtrimester sonographic visualization of fetal cardiac and craniospinal structures. Int. J. Obes. Relat. Metab. Disord. 2004, 28, 1607–1611. [Google Scholar] [CrossRef] [PubMed]
- Hendler, I.; Blackwell, S.C.; Bujold, E.; Treadwell, M.C.; Mittal, P.; Sokol, R.J.; Sorokin, Y. Suboptimal second-trimester ultrasonographic visualization of the fetal heart in obese women: Should we repeat the examination? J. Ultrasound Med. 2005, 24, 1205–1209. [Google Scholar]
- Hill, L.M. Timing of ultrasound in pregnancy—How often? At what intervals? Semin. Perinatol. 2013, 37, 327–333. [Google Scholar] [CrossRef]
- Dashe, J.S.; McIntire, D.D.; Twickler, D.M. Effect of maternal obesity on the ultrasound detection of anomalous fetuses. Obstet. Gynecol. 2009, 113, 1001–1007. [Google Scholar] [CrossRef] [PubMed]
- Hildebrand, E.; Gottvall, T.; Blomberg, M. Maternal obesity and detection rate of fetal structural anomalies. Fetal Diagn. Ther. 2013, 33, 246–251. [Google Scholar] [CrossRef] [PubMed]
- Best, K.E.; Tennant, P.W.; Bell, R.; Rankin, J. Impact of maternal body mass index on the antenatal detection of congenital anomalies. BJOG 2012, 119, 1503–1511. [Google Scholar] [CrossRef] [PubMed]
- Benacerraf, B. The use of obstetrical ultrasound in the obese gravida. Semin. Perinatol. 2013, 37, 345–347. [Google Scholar] [CrossRef] [PubMed]
- Paladini, D. Sonography in obese and overweight pregnant women: Clinical, medicolegal and technical issues. Ultrasound Obstet. Gynecol. 2009, 33, 720–729. [Google Scholar] [CrossRef] [PubMed]
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Share and Cite
Zozzaro-Smith, P.; Gray, L.M.; Bacak, S.J.; Thornburg, L.L. Limitations of Aneuploidy and Anomaly Detection in the Obese Patient. J. Clin. Med. 2014, 3, 795-808. https://doi.org/10.3390/jcm3030795
Zozzaro-Smith P, Gray LM, Bacak SJ, Thornburg LL. Limitations of Aneuploidy and Anomaly Detection in the Obese Patient. Journal of Clinical Medicine. 2014; 3(3):795-808. https://doi.org/10.3390/jcm3030795
Chicago/Turabian StyleZozzaro-Smith, Paula, Lisa M. Gray, Stephen J. Bacak, and Loralei L. Thornburg. 2014. "Limitations of Aneuploidy and Anomaly Detection in the Obese Patient" Journal of Clinical Medicine 3, no. 3: 795-808. https://doi.org/10.3390/jcm3030795